When columnist Dagmar Munn's special footwear began to wear out, she went shoe shopping — which required a certain amount of resilience.| ALS News Today
U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.| ALS News Today
Neither memantine nor trazodone was able to slow amyotrophic lateral sclerosis (ALS) disease progression in a platform clinical trial.| ALS News Today
An analysis in 62 ALS patients who followed the Phase 2b study's rules (protocol) found a 37.4% ALSFRS-R difference with PrimeC vs. placebo.| ALS News Today
Exercise has multiple benefits for people with ALS, such as preserving muscle strength and mobility, and increasing overall quality of life.| ALS News Today
Columnist Dagmar Munn explains how she moved on from a mindset of "why bother?" after her ALS diagnosis. It helps her to live well.| ALS News Today
After columnist James Clingman's ALS diagnosis, he says he feared sleep. Now, it's a welcome escape to a world of late family and friends.| ALS News Today
What columnist Dagmar Munn thought was an ALS symptom was just an impostor. "Learned nonuse" was her true problem, and she addressed it.| ALS News Today
Starting treatment with PrimeC six months sooner was associated with slower disease progression and a survival benefit for ALS patients.| ALS News Today
Inspired by the Olympic athletes at the 2024 Paris Games, columnist Dagmar Munn shares the lessons she's applying to her life with ALS.| ALS News Today